Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
419 JPY | +1.45% | -0.95% | -40.31% |
19/03 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
19/03 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
Sales 2024 | - | Sales 2025 * | - | Capitalization | 28.76B 182M 15.14B |
---|---|---|---|---|---|
Net income 2024 | -2.64B -16.69M -1.39B | Net income 2025 * | -3.3B -20.8M -1.73B | EV / Sales 2024 | - |
Net cash position 2024 * | 5.65B 35.64M 2.97B | Net Debt 2025 * | 226M 1.43M 119M | EV / Sales 2025 * | - |
P/E ratio 2024 |
-14
x | P/E ratio 2025 * |
-8.54
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.15% |
Latest transcript on SanBio Company Limited
1 day | +1.45% | ||
1 week | -0.95% | ||
Current month | -5.84% | ||
1 month | -17.84% | ||
3 months | -26.62% | ||
6 months | -6.26% | ||
Current year | -40.31% |
Managers | Title | Age | Since |
---|---|---|---|
Keita Mori
CEO | Chief Executive Officer | 56 | 27/13/27 |
Shinya Hirata
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Noboru Kotani
BRD | Director/Board Member | 67 | 01/13/01 |
Keita Mori
CEO | Chief Executive Officer | 56 | 27/13/27 |
Toru Kawanishi
CHM | Chairman | 56 | 27/13/27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 419 | +1.45% | 238,800 |
25/24/25 | 413 | -2.13% | 360,200 |
24/24/24 | 422 | +1.20% | 493,100 |
23/24/23 | 417 | -0.48% | 248,600 |
22/24/22 | 419 | -0.95% | 424,000 |
Delayed Quote Japan Exchange, April 26, 2024 at 11:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.31% | 183M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 4592 Stock